Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 6/20 | 1.00 |
| ▸ | FUCA1 | P04066 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL371513 | 1.00 | GBA1 (1.00) | GBA1FUCA1LMNAAPPSI | |
| SCHEMBL371514 | 1.00 | GBA1 (1.00) | GBA1FUCA1LMNAAPPSI | |
| SCHEMBL247045 | 1.00 | GBA1 (1.00) | GBA1FUCA1LMNAAPPSI | |
| SCHEMBL29885626 | 1.00 | GBA1 (1.00) | GBA1FUCA1LMNAAPPSI | |
| SCHEMBL371512 | 1.00 | GBA1 (1.00) | GBA1FUCA1LMNAAPPSI | |
| SCHEMBL371511 | 1.00 | GBA1 (1.00) | GBA1FUCA1LMNAAPPSI | |
| SCHEMBL14007131 | 1.00 | GBA1 (1.00) | GBA1FUCA1LMNAAPPSI | |
| SCHEMBL15926078 | 1.00 | GBA1 (1.00) | GBA1FUCA1LMNAAPPSI | |
| SCHEMBL10824967 | 1.00 | GBA1 (1.00) | GBA1FUCA1LMNAAPPSI | |
| SCHEMBL11348573 | 1.00 | GBA1 (1.00) | GBA1FUCA1LMNAAPPSI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023072971-A2 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-05-04 | — | — | WO | disclosed |
| EP-4170347-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2023-04-26 | — | — | EP | disclosed |
| WO-2019173293-A1 | AFFINITY PURIFICATION OF GLYCOSIDE-CLEAVING ENZYMES | SHIRE HUMAN GENETIC THERAPIES, INC. (US) | 2019-09-12 | — | — | WO | disclosed |